[Pain management, let us be simple but efficient].
The occurrence of pain during the course of bronchial carcinoma is nearly inescapable and often constitutes the main symptom for patients and those close to them. While pain control is held to be a priority of care in cancerology in the future, this goal is not always reached due to insufficient implementation of recommendations, however widely accessible. Our aim is to present the different aspects of pain treatment through the details of both pharmacological and nonpharmacological means.
Morel
V
V
Equipe Mobile d'Accompagnement et de Soins Palliatifs, Pôle Soins de Support, Hôpital Hôtel-Dieu, CHU de Rennes, 2 Rue de l'Hôtel-Dieu, CS 26419, 35064 Rennes Cedex, France. vincent.morel@chu-rennes.fr
Jouneau
S
S
Leveiller
G
G
Corre
R
R
Lena
H
H
D000700:Analgesics / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000503:physiopathology*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000503:physiopathology*; D010146:Pain / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*
D000700:Analgesics; D000701:Analgesics, Opioid